{"paper_id":"c23b4301-264e-467e-83ff-e5378a1358c0","body_text":"Abstract\nAlthough the etiology of endometriosis is not understood, it is known that the ectopic endometrial tissue is sensitive to the production of sex steroid hormones during the menstrual cycle. Endometriosis is rare before menarche and develops usually during the reproductive years. The importance of ovarian steroids in the development and maintenance of endometriosis is also demonstrated by the usual curative effect of oophorectomy and the spontaneous regression of the disease at menopause. Experimentally implanted endometriosis in castrated monkeys requires sex steroids for its maintenance [1].\nPreview\nUnable to display preview. Download preview PDF.\nSimilar content being viewed by others\nReferences\nDizerega, GS, Barber, DL, and Hodgen, GD (1980). Endometriosis: Role of ovarian steroids in initiation, maintenance and suppression. Fertil Steril, 33, 649\nBergquist, A, Ljungberg, O, and Myhre, E (1984). Comparison of the histological appearance of human endometrium and endometriotic tissue obtained simultaneously: A preliminary report. Acta Obstet Gynecol Scand (Suppl), 123, 11\nJanne, O, Kauppila, A, and Kokko, E (1981). Estrogen and progestin receptors in endometriotic lesions: comparison with endometrial tissue. Am J Obstet Gynecol, 141, 562\nTamaya, T, Motoyama, T, and Ohono, Y (1979). Steroid receptor levels and histology of endometriosis and adenomysis. Fertil Steril, 31, 396\nVihko, R, Isotalo, H, and Kauppila, A (1984). Hormonal regulation of endometrium and endometriosis tissue. In: Raynaud, OP (ed.) “Medical Management of Endometriosis”, p 79. (New York: Raven Press)\nKistner, RW (1958). The use of newer progestins in the treatment of endometriosis. Am J Obstet Gynecol, 75, 264\nKistner, RW (1959). The treatment of endometriosis by inducing pseudopregnancy with ovarian hormones: a report of 58 cases. Fertil Steril, 10, 539\nDmowski, WP, and Cohen, MR (1978). Antigonadotropin (danazol) in the treatment of endometriosis. Am J Obstet Gynecol, 130, 41\nBarbieri, RL, Evans, S, and Kistner, RW (1982). Danazol in the treatment of endometriosis: analysis of of 100 cases with a 4-year follow-up. Fertil Steril, 36, 737\nButtram, VC, Reiter, RC, and Ward, S (1985). Treatment of endometriosis with danazol: report of a six year prospective study. Fertil Steril, 43, 353\nLemay, A, and Quesnel, G (1982). Potential new treament of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormonereleasing hormone (LH-RH) agonist. Fertil Steril, 38, 376\nShaw, RW, Fraser, HM, and Boyle, H (1983). Intranasal treatment with luteinizing hormone releasing hormone agonist in women with endometriosis. Brit Med J, 287, 1667\nPring, DW, Maresh, M, and Fraser, AC (1983). Luteinizing hormone releasing hormone agonist in women with endometriosis. Brit Med J, 287, 1718\nLemay, A, Maheux, R, Faure, N, Jean, C, and Fazekas, ATA (1984). Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (buserelin) as a new therapeutic approach for endometriosis. Fertil Steril, 41, 863\nSchriock, E, Monroe, SE, Henzl, M, and Jaffe, RB (1985). Treatment of endometriosis with a potent agonist of gonadotropinreleasing hormone (nafarelin). Fertil Steril, 44, 583\nZorn, JR, Tanger, Ch, Roger, M, Grenier, J, Comaru-Schally, AM, and Schally, AV (1986). Therapeutic hypogonadism induced by a delayed-release preparation of microcapsules of D-Trp-6-luteinizing hormone-releasing hormone: A preliminary study in eight women with endometriosis. Int J Fertil, 3, 11\nHardt, W, Schimdt-Gollwitzer, M, Schmidt-Gollwitzer K, Genz, T, and Nevinny-Stickel, J (1986). Erst ergebnisse bei der behandlung der endometriose mit dem LH-RH-analogon buserelin. Geburtsh u Frauenheilk, 46, 483\nSteingold, KA, Cedars, M, Ju, JKH, Randle, D, Judd, HL, and Meldrum, DR (1987). Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet Gynecol, 69, 403\nLemay, A, Maheux, R, Huot, C, Blanchet, J, and Faure, N (1988). Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis. Am J Obstet Gynecol (in press)\nAmerican Fertility Society (1979). Classification of endometriosis. Fertil Steril, 32, 633\nFraser, IS, Markham, R, Mcllveen, J, and Robinson, M (1982). Dynamic tests of hypothalamic and pituitary function in women treated with danazol. Fertil Steril 37, 484\nDmowski, PW, Headley, S, and Radwanska, E (1983). Effects of danazol on pulsatile gonadotropin patterns and on serum estradiol levels in normally cycling women. Fertil Steril, 39, 49\nRannevik, G, and Thorell, JI (1984). The influence of danazol on pituitary function and on the ovarian follicular hormone secretion in premenopausal women. Acta Obstet Gynecol Scand (Suppl), 123, 89\nHardt, W, and Schmidt-Gollwitzer, M (1983). Sustained gonadal suppression in fertile women with the LHRH agonist buserelin. Clin Endocrinol, 19., 613\nMeldrum, DR, Pardridge, WM, Karow, WG, Rivier, J, Vale, W, and Judd, HL (1983). Hormonal effects of danazol and medical oophorectomy in endometriosis. Obstet Gynecol, 62, 480\nHolt, JP, and Keller, D (1984). Danazol treatment increases serum enzyme levels. Fertil Steril, 41, 70\nCann, CE, Henzl, M, Burry, K, Andreko, J, Hanson, F, Adamson, D, Trobough, G, and Strewler, G (1986). Reversible bone loss is induced by GnRH agonist. 68th Annual Meeting of the Endocrine Society, Anaheim, California, Abstract\nMatta, WH, Shaw, RW, Hesp, R, and Katz, D (1987). Hypogonadism induced by luteinizing hormone releasing hormone agonist analogues: effects on bone density in premenopausal women. Brit Med J, 294. 1523\nDevogelaer, JP, DeDeuxchaisnes, CN, Donnez, J, and Thomas, K (1987). LHRH analogues and bone loss. The Lancet, I 1498\nAuthor information\nAuthors and Affiliations\nConsortia\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 1990 Springer Science+Business Media Dordrecht\nAbout this chapter\nCite this chapter\nLemay, A., HRPI buserelin protocol 310 study group. (1990). Comparison of Buserelin to Danazol Therapy in Endometriosis. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2169-6_3\nDownload citation\nDOI: https://doi.org/10.1007/978-94-009-2169-6_3\nPublisher Name: Springer, Dordrecht\nPrint ISBN: 978-94-010-7474-2\nOnline ISBN: 978-94-009-2169-6\neBook Packages: Springer Book Archive\nKeywords\nThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.","source_license":"CC0","license_restricted":false}